| | |
| | |
| Clinical data | |
|---|---|
| Routes of administration | By mouth |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H14FN |
| Molar mass | 167.227 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
2-Fluoromethamphetamine (2-FMA) is a stimulant drug of the amphetamine family which has been used as a designer drug. [2] [3] [4] 2-FMA is commonly compared to lisdexamfetamine (Vyvanse), and dextroamphetamine due to its efficacy as a study or productivity aid.[ citation needed ] 2-FMA is purported to produce somewhat less euphoria than comparable amphetamines, likely due to its main mechanism of action consisting of norepinephrine reuptake inhibition. [5] [ failed verification ]
2-Fluoromethamphetamine is fluorinated analogue of methamphetamine, and is a regioisomer of 3-FMA and 4-FMA.
It does not activate the serotonin receptors, including 5-HT2A, [5] unlike most stimulant drugs of the amphetamine family.
As of 1996, 2-FMA is a controlled substance in Canada, due to being an analog of methamphetamine. [1]
As of October 2015, 2-FMA is a controlled substance in China. [6]
As of 13 December 2014, 2-FMA is a controlled substance in Germany. [7] It is controlled under Anlage I BtMG (Narcotics Act, Schedule I). [8] Substances controlled under Anlage I BtMG are illegal to manufacture, possess, import, export, buy, sell, procure or dispense without a license. Violations of the law are punishable by a fine or imprisonment for up to five years. [9]
As of July 2019, 2-FMA is a controlled substance in Ukraine (considered a narcotic). [10]
As a close analog of scheduled controlled substance, [2] sale or possession of 2-FMA could be potentially be prosecuted under the Federal Analogue Act. [11]